Skip to search.
 BSE Up0.19% NSE Up0.28%

Valeant Pharmaceuticals International, Inc. (VRX)

-NYSE

78.17 Up 2.42(3.19%) 18 May 1:35AM

Add to Portfolio
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Sep 2010		Next Qtr.
Dec 2010		Current Year
Dec 2010		Next Year
Dec 2011
Avg. EstimateN/AN/AN/AN/A
No. of AnalystsN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago EPS0.580.67N/AN/A
Revenue EstCurrent Qtr.
Sep 2010		Next Qtr.
Dec 2010		Current Year
Dec 2010		Next Year
Dec 2011
Avg. Estimate297.08M307.13M1.09B1.26B
No. of Analysts5566
Low Estimate270.80M288.90M1.05B1.14B
High Estimate333.00M331.70M1.15B1.40B
Year Ago Sales220.32M240.52M830.46M1.09B
Sales Growth (year/est)34.80%27.70%30.90%15.60%
Earnings HistorySep 2009Dec 2009Mar 2010Jun 2010
EPS Est0.490.590.590.63
EPS Actual0.580.670.640.69
Difference0.090.080.050.06
Surprise %18.40%13.60%8.50%9.50%
EPS TrendsCurrent Qtr.
Sep 2010		Next Qtr.
Dec 2010		Current Year
Dec 2010		Next Year
Dec 2011
Current EstimateN/AN/AN/AN/A
7 Days Ago0.810.822.943.34
30 Days Ago0.810.822.943.34
60 Days Ago0.810.822.943.34
90 Days Ago0.810.822.943.34
EPS RevisionsCurrent Qtr.
Sep 2010		Next Qtr.
Dec 2010		Current Year
Dec 2010		Next Year
Dec 2011
Up Last 7 Days0000
Up Last 30 Days0000
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstVRXIndustrySectorS&P 500
Current Qtr.N/A17.60%N/A11.80%
Next Qtr.N/A21.40%N/A16.60%
This YearN/A17.50%9.70%9.10%
Next YearN/A25.80%13.20%12.60%
Past 5 Years (per annum)61.43%N/AN/AN/A
Next 5 Years (per annum)15.24%15.78%13.69%9.37%
Price/Earnings (avg. for comparison categories)N/A19.123.2113.29
PEG Ratio (avg. for comparison categories)N/A1.78-0.681.32
Currency in USD.